Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001411920-16-000005
Filing Date
2016-11-09
Accepted
2016-11-09 15:17:55
Documents
1
Effectiveness Date
2016-11-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12658
  Complete submission text file 0001411920-16-000005.txt   13815
Mailing Address 654 MADISON AVENUE SUITE 1601 New York NY 10065
Business Address 654 MADISON AVENUE SUITE 1601 New York NY 10065 212-582-1199
IRX Therapeutics, Inc. (Filer) CIK: 0001411920 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-274149 | Film No.: 161983895